References
- Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(Suppl S29):1–464.
- Jaume F, Alobid I, Mullol J, et al. Direct costs of acute rhinosinusitis in Spain: a Prospective and Observational Study (PROSINUS). J Investig Allergol Clin Immunol. 2021 Dec 21;31(6):481–488.
- Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 Mar;11(3):213–739.
- Stjarne P, Odeback P, Stallberg B, et al. High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care. Prim Care Respir J. 2012 Jun;21(2):174–179.
- Jaume F, Quinto L, Alobid I, et al. Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ Open. 2018 Jan 31;8(1):e018788.
- Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015 Apr;40(4):277–283.
- Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V., Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V. Rhinosinusitis, 2k-Leitlinie, AWMF-Register-Nr. 017/049 und p. 053–012. 2017.
- Kreindler JL, Chen B, Kreitman Y, et al. The novel dry extract BNO 1011 stimulates chloride transport and ciliary beat frequency in human respiratory epithelial cultures. Am J Rhinol Allergy. 2012;26(6):439–443. doi: 10.2500/ajra.2012.26.3821
- Zhang S, Skinner D, Hicks SB, et al. Sinupret activates CFTR and TMEM16A-dependent transepithelial chloride transport and improves indicators of mucociliary clearance. PLoS One. 2014;9(8):e104090. doi: 10.1371/journal.pone.0104090
- Cho DY, Skinner D, Mackey C, et al. Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019 Jun;9(6):629–637.
- Workman AD, Maina IW, Triantafillou V, et al. Effects of BNO 1016 on ciliary transport velocity and cell culture surface liquid height of sinonasal epithelial cultures. Clin Phytosci. 2021;7(1): doi: 10.1186/s40816-021-00276-2
- Rossi A, Dehm F, Kiesselbach C, et al. The novel Sinupret® dry extract exhibits anti-inflammatory effectiveness in vivo. Fitoterapia. 2012 Jun;83(4):715–720.
- Zupanets IA, Shebeko SK, Popovych VI, et al. Study of the anti-inflammatory effect of the combined extract BNO 1016 in a leukotriene-dependent in vivo inflammation model. Clin Phytosci. 2020;6(1). doi: 10.1186/s40816-020-0153-8
- Glatthaar-Saalmüller B, Rauchhaus U, Rode S, et al. Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret® against viruses causing respiratory infections. Phytomedicine. 2011;19(1):1–7. doi: 10.1016/j.phymed.2011.10.010
- Tran HTT, Peterburs P, Seibel J, et al. In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2. Evid Based Complement Alternat Med. 2022;2022:1–9. doi: 10.1155/2022/8038195
- Cochrane A. Effectiveness and efficiency: random reflections on health services. The Nuffield Provincial Hospitals Trust, London, UK; 1972.
- Haynes B. Can it work? Does it work? Is it worth it? BMJ. 1999;319(7211):652–653. doi: 10.1136/bmj.319.7211.652
- Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence — what is it and what can it tell us? N Engl J Med. 2016;375(23):2293–2297. doi: 10.1056/NEJMsb1609216
- Concato J, Corrigan-Curay J. Real-World Evidence — Where are we now? N Engl J Med. 2022;386(18):1680–1682. doi: 10.1056/NEJMp2200089
- Jund R, Mondigler M, Stammer H, et al. Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. 2015;135(1):42–50. doi: 10.3109/00016489.2014.952047
- Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005 Dec;116(6):1289–1295. doi: 10.1016/j.jaci.2005.08.044
- Jund R, Mondigler M, Steindl H, et al. Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology. 2012 Dec;50(4):417–426.
- Rathmann W, Bongaerts B, Carius H-J, et al. Basic characteristics and representativeness of the German disease analyzer database. Int J Clin Pharm Therap. 2018;56(10):459–466. doi: 10.5414/CP203320
- DeBoer DL, Kwon E. Acute sinusitis. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright© 2022. Florida, USA: StatPearls Publishing LLC; 2022.
- Hopkins C, Surda P, Walker A, et al. EPOS 4 Patients. Rhinology. 2021 Oct 29:1–57. doi: 10.4193/Rhin20.950
- Wiebringhaus R, Haubner F. Acute Rhinosinusitis - an update on therapy. MMW Fortschr Med. 2022 Mar;164(5):40–43. doi: 10.1007/s15006-022-0777-3
- Bittner CB, Plach M, Steindl H, et al. Prevalence of antibiotic prescription in patients with acute rhinosinusitis treated by general practitioners and otolaryngologists in Germany- A retrospective cohort study. Antibiotics (Basel). 2022 Nov 9;11(11):1576.
- Pouwels KB, Dolk FCK, Smith DRM, et al. Actual versus ‘ideal’ antibiotic prescribing for common conditions in English primary care. J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):19–26.
- Schwartz KL, Langford BJ, Daneman N, et al. Unnecessary antibiotic prescribing in a Canadian primary care setting: a descriptive analysis using routinely collected electronic medical record data. CMAJ Open. 2020 Apr;8(2):E360–e369.
- Havers FP, Hicks LA, Chung JR, et al. Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons. JAMA Netw Open. 2018 Jun 1;1(2):e180243.
- Truitt KN, Brown T, Lee JY, et al. Appropriateness of antibiotic prescribing for acute sinusitis in primary care: a cross-sectional study. Clin Infect Dis. 2021 Jan 27;72(2):311–314.
- Smith SS, Caliendo A, Cheng BT, et al. Patient perspectives on the drivers and deterrents of antibiotic treatment of acute rhinosinusitis: a qualitative study. J Gen Intern Med. 2023 Feb;38(3):683–690.
- Martin D, Konrad M, Adarkwah CC, et al. Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals- a retrospective cohort study. Postgrad Med. 2020 Jun;132(5):412–418.
- Bachert C. Evidence-based management of acute rhinosinusitis with herbal products. Clin Phytosci. 2020;6(1). doi: 10.1186/s40816-020-00231-7
- Dejaco D, Bocian-Sobkowska J, Szymanski W, et al. Tavipec in acute rhinosinusitis: a multi-centre, doubleblind, randomized, placebo-controlled, clinical trial. Rhinology. 2019 Oct 1;57(5):367–374.
- European Commission. EU Guidelines for the prudent use of antimicrobials in human health. Off J Eur Union 2017 [1 Jul 2017];C212:1–12.
- Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–433. doi: 10.1128/MMBR.00016-10
- Collaborators EAR. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. Lancet Public Health. 2022 Nov;7(11):e897–e913. doi: 10.1016/S2468-2667(22)00225-0
- Nausch B, Bittner CB, Höller M, et al. Contribution of symptomatic, herbal treatment options to antibiotic stewardship and microbiotic health. Antibiotics (Basel). 2022 Sep 29;11(10). doi: 10.3390/antibiotics11101331
- Lange K, Buerger M, Stallmach A, et al. Effects of antibiotics on gut microbiota. Dig Dis. 2016;34(3):260–268. doi: 10.1159/000443360